Taking into account the frequency of LRRK2 gene abnormalities in familial and sporadic PD, the investigation of the molecular pathways influenced by mutant LRRK2 is particularly intriguing, and will potentially lead to the identification of effective neuroprotective therapies suitable for a large number of patients. The gene discussed is LRRK2; the disease is Parkinson disease.